Genomic Health Upgraded By Canaccord, $44 Per Share Target Predicted

By: via Benzinga
Shares of Genomic Health, Inc. (NASDAQ: GHDX) were trading higher by more than 2.5 percent on Wednesday following a nod of confidence ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.